Compare HCA Health Inc (HCA) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Meta Platforms Inc — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Meta Platforms Inc trades at $721.21 (market cap $1.84T). The key difference: Meta Platforms Inc is far larger — about 19.4× HCA Health Inc's market cap, and HCA Health Inc pays the higher dividend (0.71%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Meta Platforms Inc for 127 Days on average.
| HCA | META | |
|---|---|---|
Market Cap | $95.08B | $1.84T |
Volume | 998,787 | 12,743,601 |
Sector | Health | Media |
52-Week High | $545.13 | $777.59 |
52-Week Low | $361.32 | $525.72 |
Typical Hold Time | 76 Days | 127 Days |
Enterprise Value | $145.62B | $1.86T |
Dividend Yield | 0.71% | 0.29% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Meta Platforms (META) trades at $720.89, down 2.43% on the day, with strong bullish technical signals from moving averages. The company demonstrates robust fundamentals with $201B revenue in 2025 and 29.8% net income margin, though Q2 2026 earnings missed expectations. Recent AI developments including the Muse Spark launch and a $21B partnership with CoreWeave highlight growth initiatives. Analyst consensus remains strongly bullish with 80% buy ratings and a $781 price target.
Meta presents a compelling investment case with strong profitability metrics and AI-driven growth potential, though faces regulatory risks from ongoing litigation and significant capital expenditure requirements. The stock's current valuation at 27x P/E appears reasonable given growth prospects, but investors should monitor execution on AI monetization and legal developments that could impact future earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
